Mechanisms of Cerebrovascular Amyloid Deposition: Lessons from Mouse Models

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2000-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1749-6632.2000.tb06381.xPMID 10818520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebrovascular involvement in systemic AA and AL amyloidosis: a clear haematogenic pattern

  1999cited by this paper
• Amyloid β precursor protein-mRNA is expressed throughout cerebral vessel walls

  1999cited by this paper
• Gelsolin‐related spinal and cerebral amyloid angiopathy

  1999cited by this paper
• High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.

  1999cited by this paper
• Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

  1999cited by this paper
• Cerebrovascular amyloidosis: experimental analysis in vitro and in vivo.

  1999cited by this paper
• A stop-codon mutation in the BRI gene associated with familial British dementia

  1999cited by this paper
• Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls.

  1999cited by this paper
• Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

  1999cited by this paper
• Pathology of Cerebrospinal Fluid and Interstitial Fluid of the CNS: Significance for Alzheimer Disease, Prion Disorders and Multiple Sclerosis

  1998cited by this paper
• Pathologic Amyloid β‐Protein Cell Surface Fibril Assembly on Cultured Human Cerebrovascular Smooth Muscle Cells

  1998cited by this paper
• Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

  1998cited by this paper
• Cerebrovascular Accumulation and Increased Blood‐Brain Barrier Permeability to Circulating Alzheimer's Amyloid β Peptide in Aged Squirrel Monkey with Cerebral Amyloid Angiopathy

  1998cited by this paper
• Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease.

  1998cited by this paper
• Transgenic and Knockout Mice in Research on Prion Diseases

  1998cited by this paper
• Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells.

  1998cited by this paper
• Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.

  1998cited by this paper
• Animal models of cerebral beta-amyloid angiopathy.

  1997cited by this paper
• Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease

  1997cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997cited by this paper
• In vivo vascular damage, leukocyte activation and inflammatory response induced by beta-amyloid.

  1997cited by this paper
• The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations.

  1997cited by this paper
• Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy.

  1997cited by this paper
• Rapid degeneration of cultured human brain pericytes by amyloid beta protein.

  1997cited by this paper
• Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier.

  1997cited by this paper
• Transthyretin amyloidosis: A new mutation associated with dementia

  1997cited by this paper
• Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease.

  1997cited by this paper
• Rapid Degeneration of Cultured Human Brain Pericytes by Amyloid β Protein

  1997cited by this paper
• Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.

  1997influential reference
• Cystatin C. Icelandic-like mutation in an animal model of cerebrovascular beta-amyloidosis.

  1996cited by this paper
• Dystroglycan in the Cerebellum is a Laminin α2‐chain Binding Protein at the Glial‐Vascular Interface and is Expressed in Purkinje cells

  1996cited by this paper
• Accumulation of beta-amyloid fibrils in pancreas of transgenic mice.

  1996cited by this paper
• Cerebral vessels in ageing and Alzheimer's disease.

  1996cited by this paper
• Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease.

  1996cited by this paper
• Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Cystatin C Icelandic-Like Mutation in an Animal Model of Cerebrovascular β-Amyloidosis

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice.

  1996cited by this paper
• Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay*

  1996cited by this paper
• Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.

  1996cited by this paper
• Intra-arterial infusion of [125I]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo.

  1996cited by this paper
• Accumulation of β-Amyloid fibrils in pancreas of transgenic mice

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice

  1996cited by this paper
• Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1.

  1995cited by this paper
• Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.

  1995cited by this paper
• Amyloid β‐Protein Induces Its Own Production in Cultured Degenerating Cerebrovascular Smooth Muscle Cells

  1995cited by this paper
• An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease.

  1995cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells.

  1995cited by this paper
• Levels and Alternative Splicing of Amyloid β Protein Precursor (APP) Transcripts in Brains of APP Transgenic Mice and Humans with Alzheimer's Disease (*)

  1995cited by this paper
• Amyloid β‐proteins 1—40 and 1—42(43) in the soluble fraction of extra‐ and intracranial blood vessels

  1995cited by this paper
• Amyloid β protein levels in cerebrospinal fluid are elevated in early‐onset Alzheimer's disease

  1994cited by this paper
• An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain.

  1994cited by this paper
• Normal and abnormal biology of the beta-amyloid precursor protein.

  1994cited by this paper
• Vascular β-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells

  1994cited by this paper
• Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease.

  1994cited by this paper
• An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain

  1994cited by this paper
• Beta-amyloid formation by myocytes of leptomeningeal vessels.

  1994cited by this paper
• Amyloid βprotein precursor in cultured leptomeningeal smooth muscle cells

  1994cited by this paper
• beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.

  1993cited by this paper
• Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.

  1993cited by this paper
• Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly.

  1993cited by this paper
• Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.

  1992cited by this paper
• Characterization of Alzheimer amyloid precursor protein transcripts in platelets and megakarocytes.

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study

  1991cited by this paper
• Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin.

  1990cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Structure and expression of the human cystatin C gene.

  1990cited by this paper
• Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease

  1988cited by this paper
• Cerebral amyloid angiopathy in the aged

  1987cited by this paper
• Cerebral amyloid angiopathy. A critical review.

  1987cited by this paper
• Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C).

  1986cited by this paper

• Endothelial expression of human amyloid precursor protein leads to amyloid β in the blood and induces cerebral amyloid angiopathy in knock-in mice

  2022cites this paper
• The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease

  2020influential citation
• From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-β Formation

  2019cites this paper
• NEUROPATHOLOGICAL AND GENETIC DETERMINANTS OF DEMENTIA: A PROSPECTIVE AND POPULATION-BASED STUDY ON VERY ELDERLY FINNS

  2018cites this paper
• Cerebral amyloid angiopathy: Review of clinico‐radiological features and mimics

  2018cites this paper
• Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease

  2017cites this paper
• Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β‐amyloid fibrinogen interaction

  2016cites this paper
• Amyloid-β and chronic cerebral hypoperfusion in the early pathogenesis of Alzheimer’s disease

  2016cites this paper
• [Sporadic Cerebral Amyloid Angiopathy: An Overview with Clinical Cases].

  2016cites this paper
• Applied clinical neuroimaging in cerebral amyloid angiopathy and spontaneous intracerebral haemorrhage

  2015cites this paper
• APOE and cerebral amyloid angiopathy in community-dwelling older persons.

  2015cites this paper
• Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease.

  2014cites this paper
• Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes

  2014cites this paper
• Insulin-degrading enzyme deficiency accelerates cerebrovascular amyloidosis in an animal model.

  2013cites this paper
• Cerebral Amyloidal Angiopathy--a disease with implications for neurology and psychiatry.

  2013cites this paper
• Hereditary and sporadic beta-amyloidoses.

  2013cites this paper
• Oligomeric Pyroglutamate Amyloid-β is Present in Microglia and a Subfraction of Vessels in Patients with Alzheimer's Disease: Implications for Immunotherapy

  2013cites this paper
• A Longitudinal Study of Cognition, Proton MR Spectroscopy and Synaptic and Neuronal Pathology in Aging Wild-type and AβPPswe-PS1dE9 Mice

  2013cites this paper
• Monitoring Alzheimer's disease in transgenic mice with ultra high field magnetic resonance imaging

  2013cites this paper
• The role of nutrition in Alzheimer’s disease : a study in transgenic mouse models for Alzheimer’s disease and vascular disorders

  2013cites this paper
• Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6 T

  2012cites this paper
• The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.

  2012cites this paper
• FMRI in Mice: Functional Phenotyping of Transgenic Mouse Lines Based on Hemodynamic Readouts

  2012cites this paper
• Genetic animal models of cerebral vasculopathies.

  2012cites this paper
• Zerebrale Amyloidangiopathie – ein Update

  2012cites this paper
• The Pathophysiology and Clinical Presentation of Cerebral Amyloid Angiopathy

  2012cites this paper
• Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy.

  2012cites this paper
• Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation.

  2012cites this paper
• Overview of Mouse Models for Psychiatric and Neurologic Disorders

  2012cites this paper
• Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.

  2012cites this paper
• Immunotherapy of cereberovascular amloidosis in a transgenic mouse model

  2011cites this paper
• Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum

  2011cites this paper
• A&bgr;-Degrading Enzymes: Potential for Treatment of Alzheimer Disease

  2011cites this paper
• Cerebral Amyloid Angiopathy: A Systematic Review

  2011cites this paper
• Neprilysin Protects against Cerebral Amyloid Angiopathy and Aβ‐Induced Degeneration of Cerebrovascular Smooth Muscle Cells

  2011cites this paper
• Unveiling Molecular Events in the Brain by Noninvasive Imaging

  2011cites this paper
• A negative search of acute canine distemper virus infection in DogSLAM transgenic C57BL/6 mice.

  2010cites this paper
• LRP1 and cerebral amyloid angiopathy

  2009cites this paper
• Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy.

  2009cites this paper
• Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies

  2009cites this paper
• Amyloid diseases at old age : a pathological, epidemiological, and genetic study

  2008cites this paper
• Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy.

  2008cites this paper
• Domain swapping as a molecular mechanism in amyloidosis

  2007cites this paper
• Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.

  2007influential citation
• Mechanisms of amyloid plaque pathogenesis

  2007cites this paper
• Magnetic Resonance Imaging and Spectroscopy in Transgenic Mice Modeling Alzheimer’s Disease

  2006cites this paper
• Studies on the first described Alzheimer's disease amyloid beta mutant, the Dutch variant.

  2006cites this paper
• Studies on the first described Alzheimer's disease amyloid β mutant, the Dutch variant

  2006cites this paper
• The Role of Cystatin C in Cerebral Amyloid Angiopathy and Stroke: Cell Biology and Animal Models

  2006cites this paper
• Anti-inflammatory cytokines in cystic fibrosis lung disease

  2006cites this paper
• Cortical Cholinergic Deafferentation Induces Aβ Deposition

  2005cites this paper
• Evaluation of drug candidates: efficacy readouts during lead optimization.

  2005cites this paper
• Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms

  2005cites this paper
• Cerebral Amyloid Angiopathy: New Insights from Transgenic Mice

  2004cites this paper
• Induction of Brain-Derived Neurotrophic Factor in Plaque-Associated Glial Cells of Aged APP23 Transgenic Mice

  2004cites this paper
• Magnetic resonance angiography and vascular corrosion casting as tools in biomedical research: application to transgenic mice modeling Alzheimer's disease

  2004cites this paper
• P2-062 Induction of brain-derived neurotrophic factor (BDNF) in plaque-associated glial cells of aged APP23 transgenic mice

  2004cites this paper
• Severe Cerebral Amyloid Angiopathy Characterizes an Underestimated Variant of Vascular Dementia

  2004cites this paper
• Modulation of voltage-gated potassium channels in human T lymphocytes by extracellular glutamate.

  2004cites this paper
• Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage.

  2004cites this paper
• Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View

  2003cites this paper
• Enhanced Disease and Pulmonary Eosinophilia Associated with Formalin-Inactivated Respiratory Syncytial Virus Vaccination Are Linked to G Glycoprotein CX3C-CX3CR1 Interaction and Expression of Substance P

  2003cites this paper
• Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease

  2003influential citation
• Von Willebrand factor promoter targets the expression of amyloid β protein precursor to brain vascular endothelial cells of transgenic mice

  2003cites this paper
• Pathogenesis of cerebral amyloid angiopathy.

  2003cites this paper
• Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice

  2002cites this paper
• Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice.

  2002cites this paper
• Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in a Mouse Model of Amyloidosis

  2002cites this paper
• Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy

  2001cites this paper
• Schon gegen Alzheimer geimpft? - Mechanismen zerebraler Amyloidosen

  2001cites this paper
• Cerebrovascular risk factors for dementia

  2001cites this paper
• Cerebral microvascular pathology in aging and Alzheimer's disease.

  2001cites this paper